Skip to content

Other product segments

Health
114.6%0.0%
Multiline
90.2%-4.4%
Property
48.1%-2.4%
Financial
28%-31.0%
Casualty
23.2%-1.7%

Similar metrics at other companies

SiriusPoint logo
SPNTOther Specialties — Year 1
43.9%+2.6pp
Horace Mann Educators logo
HMNSpecialty Health — Year One
61.3%-8.1pp
White Mountains Insurance Group logo
WTMSpecialty — Prior Year
-$6.8M-179%
Kemper logo
KMPRSpecialty Personal Automobile Insurance—Liability — Year 1
37.2%-0.8pp
White Mountains Insurance Group logo
WTMSpecialty — 2
26.8%-4.0pp
Skyward Specialty Insurance Group, Inc. logo
SKWDShort-tail/Monoline Specialty Lines — Year 1
21.1%-0.7pp

Other financials

Income statement

See full
Revenue$189.7M-11.1%
Net income$35.8M+20.7%
EPS (diluted)$1.05+22.1%

Balance sheet

See full
Cash & equivalents$610.2M-5.1%
Total debt$4.7M-92.1%
Total equity$741.2M+11.2%
Total assets$2.3B+5.4%

Cash flow

See full
Operating cash flow$37.2M+259%

Valuation

See full
Market cap$533.32M+7.2%
Enterprise value-$72.18M-15.4%
P/E6.6×
P/S0.8×+0.1×

Profitability

See full
Net margin11.5%
FCF margin-46.7%

Returns & leverage

See full
Return on equity11.5%
Debt / equity-0.1×

Where this comes from

Reported directly by Greenlight Capital RE, Ltd. in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.

The official record: Greenlight Capital RE, Ltd.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Greenlight Capital RE, Ltd.'s specialty — year 1.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Greenlight Capital RE, Ltd.'s specialty — year 1?
Greenlight Capital RE, Ltd. (GLRE) reported specialty — year 1 of 26.6% in Q4 2025.
What does specialty — year 1 mean?
This metric represents the specialty segment's underwriting performance or claims development during the first year of a policy cohort. It is used to analyze the initial loss emergence and profitability trends for the most recent underwriting period. Investors use this to gauge the immediate impact of current specialty underwriting decisions.